These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators. Tovmasyan A; Sheng H; Weitner T; Arulpragasam A; Lu M; Warner DS; Vujaskovic Z; Spasojevic I; Batinic-Haberle I Med Princ Pract; 2013; 22(2):103-30. PubMed ID: 23075911 [TBL] [Abstract][Full Text] [Related]
33. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity. Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516 [TBL] [Abstract][Full Text] [Related]
34. Anti-superoxide and anti-peroxynitrite strategies in pain suppression. Janes K; Neumann WL; Salvemini D Biochim Biophys Acta; 2012 May; 1822(5):815-21. PubMed ID: 22200449 [TBL] [Abstract][Full Text] [Related]
35. Manganese superoxide dismutase, MnSOD and its mimics. Miriyala S; Spasojevic I; Tovmasyan A; Salvemini D; Vujaskovic Z; St Clair D; Batinic-Haberle I Biochim Biophys Acta; 2012 May; 1822(5):794-814. PubMed ID: 22198225 [TBL] [Abstract][Full Text] [Related]
36. Involvement of NOX1/NADPH oxidase in morphine-induced analgesia and tolerance. Ibi M; Matsuno K; Matsumoto M; Sasaki M; Nakagawa T; Katsuyama M; Iwata K; Zhang J; Kaneko S; Yabe-Nishimura C J Neurosci; 2011 Dec; 31(49):18094-103. PubMed ID: 22159121 [TBL] [Abstract][Full Text] [Related]
37. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142 [TBL] [Abstract][Full Text] [Related]
38. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins. Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047 [TBL] [Abstract][Full Text] [Related]
39. A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon. Batinic-Haberle I; Rajic Z; Benov L Anticancer Agents Med Chem; 2011 May; 11(4):329-40. PubMed ID: 21355843 [TBL] [Abstract][Full Text] [Related]
40. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]